MedNation AG (FRA:EIF) Return-on-Tangible-Equity: 26.51% (As of Dec. 2025)


FRA:EIF MedNation AG FRA:EIF
67 GF Score
Price €4.10
GF Value €2.35
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MedNation AG Return-on-Tangible-Equity?

MedNation AG FRA:EIF +1.49% 67 Return-on-Tangible-Equity is 26.51% as of Dec. 2025. GuruFocus rates FRA:EIF with a GF Score™ of 67/100 and a GF Value™ of €2.35 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 580 Healthcare Providers & Services companies, MedNation AG ranks better than 67.07% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. MedNation AG's annualized net income for the quarter that ended in Dec. 2025 was €3.49 Mil. MedNation AG's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €13.16 Mil. Therefore, MedNation AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 26.51%.

The historical rank and industry rank for MedNation AG's Return-on-Tangible-Equity or its related term are showing as below:

FRA:EIF' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -36.24   Med: -2.78   Max: 27.87
Current: 19.9

During the past 13 years, MedNation AG's highest Return-on-Tangible-Equity was 27.87%. The lowest was -36.24%. And the median was -2.78%.

FRA:EIF's Return-on-Tangible-Equity is ranked better than
67.07% of 580 companies
in the Healthcare Providers & Services industry
Industry Median: 10.065 vs FRA:EIF: 19.90

MedNation AG  (FRA:EIF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


MedNation AG Return-on-Tangible-Equity Related Terms


MedNation AG Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for MedNation AG's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedNation AG Return-on-Tangible-Equity Chart

MedNation AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -36.24 -19.72 4.60 0.72 19.66

MedNation AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.78 8.89 -7.53 12.89 26.51

FRA:EIF vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison

For the Medical Care Facilities subindustry, MedNation AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedNation AG Return-on-Tangible-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedNation AG's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where MedNation AG's Return-on-Tangible-Equity falls into.


FRA:EIF
67GF Score
MedNation AG FRA:EIF
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedNation AG Return-on-Tangible-Equity Calculation

MedNation AG's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=2.513/( (11.559+14.003 )/ 2 )
=2.513/12.781
=19.66 %

MedNation AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=3.488/( (12.313+14.003)/ 2 )
=3.488/13.158
=26.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 26.51% mean?
MedNation AG (FRA:EIF) has a Return-on-Tangible-Equity of 26.51% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MedNation AG and its competitors. According to the industry distribution chart, MedNation AG ranks #191 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 32.9%.
Is MedNation AG's Return-on-Tangible-Equity too high?
MedNation AG's current Return-on-Tangible-Equity is 26.51%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. MedNation AG's value of 26.51% is 163.4% above this industry median. Based on the distribution chart, MedNation AG ranks #191 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MedNation AG has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedNation AG's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MedNation AG ranks #191 out of 580 companies for Return-on-Tangible-Equity. This puts MedNation AG in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.07. MedNation AG's value of 26.51% is 163.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedNation AG's current Return-on-Tangible-Equity of 26.51% is 163.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MedNation AG and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedNation AG's current Return-on-Tangible-Equity is 26.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedNation AG stock overvalued right now?
Based on GuruFocus' analysis, MedNation AG (FRA:EIF) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.35, compared to a current price of €4.10 — trading 74.5% above its estimated fair value. The current Return-on-Tangible-Equity is 26.51% and 163.4% above the Healthcare Providers & Services industry median of 10.07. MedNation AG's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For MedNation AG (FRA:EIF), the current Return-on-Tangible-Equity is 26.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedNation AG (FRA:EIF) Overvalued in 2026?

Based on GuruFocus' analysis, MedNation AG stock appears to be overvalued. The current stock price of €4.10 is trading 74.5% above its estimated GF Value™ of €2.35. GuruFocus considers MedNation AG to be Significantly Overvalued.

Key valuation signals for FRA:EIF:

  • Return-on-Tangible-Equity: 26.51%
  • GF Value™: €2.35 vs. price of €4.10 (74.5% above fair value)
  • GF Score™: 67/100 with 6 warning signs
  • Industry Position: 163.4% above the Healthcare Providers & Services median (#191 of 580)

No single metric tells the full story. See the FRA:EIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedNation AG Business Description

Other Exchanges EIF:Germany
Address Graurheindorfer Strasse 137, Bonn, NW, DEU, 53117
MedNation AG operates rehabilitation hospitals. It has been operating facilities for rehabilitation, geriatric care and outpatient medical care at several locations for decades. The business purpose of MedNation AG also includes the development of independent outpatient centers as central, multidisciplinary medical centers to support freelance KV outpatient, specialist and medical-related care, especially in rural regions of Germany.
67GF Score

Get the complete analysis for FRA:EIF

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.10
Price
€2.35
GF Value